Mapping interictal activity in epilepsy using a hidden Markov model: a magnetoencephalography study by Seedat, Z, Rier, L, Gascoyne, L, Cook, H, Woolrich, M, Quinn, A, Roberts, T, Furlong, P, Armstrong, C, St Pier, K, Mullinger, K, Marsh, E, Brookes, M, Gaetz, W

Mild traumatic brain injury impairs the coordination of intrinsic and motor-related neural dynamics by Rier, L, Zamyadi, R, Zhang, J, Emami, Z, Seedat, Z, Mocanu, S, Gascoyne, L, Allen, C, Scadding, J, Furlong, P, Gooding-Williams, G, Woolrich, M, Evangelou, N, Brookes, M, Dunkley, B

A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy by Victor, RG, Sweeney, HL, Finkel, R, McDonald, CM, Byrne, B, Eagle, M, Goemans, N, Vandenborne, K, Dubrovsky, AL, Topaloglu, H, Miceli, MC, Furlong, P, Landry, J, Elashoff, R, Tadalafil DMD Study Group, Servais, L

Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint by Servais, L, Strijbos, P, Poleur, M, Mirea, A, Butoianu, N, Sansone, VA, Vuillerot, C, Schara-Schmidt, U, Scoto, M, Seferian, AM, Previtali, SC, Tulinius, M, Nascimento, A, Furlong, P, Singh, T, Dreghici, RD, Goemans, N, Mercuri, E, Straub, V, Ormazabal, MG, Braid, J, Muntoni, F, Tricot, A, Annoussamy, M

Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy by Straub, V, Balabanov, P, Bushby, K, Ensini, M, Goemans, N, De Luca, A, Pereda, A, Hemmings, R, Campion, G, Kaye, E, Arechavala-Gomeza, V, Goyenvalle, A, Niks, E, Veldhuizen, O, Furlong, P, Stoyanova-Beninska, V, Wood, M, Johnson, A, Mercuri, E, Muntoni, F, Sepodes, B, Haas, M, Vroom, E, Aartsma-Rus, A